New India-UK research to trial easy-to-use test to cut antibiotic resistance

DOSA2, as the latest phase is known, is coordinated by the University of Edinburgh and includes partners at the University of the Arts London, Silchar Medical College, Assam University and the IIT Delhi. "Through our work, we hope to help slow the emergence of drug-resistant infections and improve the ability to diagnose and treat them," said Dr Mike Strange, Head of Global Health, LifeArc.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kBe0Swl
via IFTTT